Upgrade

Drugs Made In America Acquisiti

DMIIU

Last
$10.23
Day
+0.3%
1y
+2.1%
5y
+2.1%
52w
-5.6%
SPY YTD
+13.3%
XLF
-1.3%
Earnings
—
EMA 21
10.19
EMA 50
10.15
EMA 200
10.06
20d high
-0.5%
5y high
-5.6%
5y range
31th
United States

Positions held

Your positions

DMIIU isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
18
Hold
swing
Signal
Buy
Target
$10.29
Stop
$10.15
Stop distance
0.8%
Target vs last
+0.6%

Fundamentals

Market cap—Enterprise value$650.02MTrailing P/E—Forward P/E—
PEG—Price / book-36.30Beta—Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE—ROA—Debt / equity—
Current ratio0.34Free cash flow—Analyst recommendationnoneMean target—
52w high$10.8052w low$9.96

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M—
Op margin——————
Net income$4.4M$4.3M$4.3M-$0.0M-$0.0M—
Gross margin——————
Gross profit——————
Operating income-$0.1M-$0.1M-$1.0M-$0.2M-$0.0M—

Yearly (6y)

2025
Revenue$0.0M
Op margin—
Net income$4.2M
Gross margin—
Gross profit—
Operating income-$1.3M
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

No headlines.

DMIIU · daily+0.3% over 12 sessions
Close EMA21 EMA50 EMA200
10.1710.1910.2110.2310.252026-082026-092026-092026-092026-092026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$0M$1M$2M$3M$4M0%5%10%2025-Q22025-Q32025-Q42026-Q12026-Q2